Literature DB >> 34257293

Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted.

J Mario Isas1, Nitin K Pandey1, Hui Xu1, Kazuki Teranishi1, Alan K Okada1,2, Ellisa K Fultz1, Anoop Rawat1, Anise Applebaum1, Franziska Meier1, Jeannie Chen1, Ralf Langen3, Ansgar B Siemer4.   

Abstract

The first exon of the huntingtin protein (HTTex1) important in Huntington's disease (HD) can form cross-β fibrils of varying toxicity. We find that the difference between these fibrils is the degree of entanglement and dynamics of the C-terminal proline-rich domain (PRD) in a mechanism analogous to polyproline film formation. In contrast to fibril strains found for other cross-β fibrils, these HTTex1 fibril types can be interconverted. This is because the structure of their polyQ fibril core remains unchanged. Further, we find that more toxic fibrils of low entanglement have higher affinities for protein interactors and are more effective seeds for recombinant HTTex1 and HTTex1 in cells. Together these data show how the structure of a framing sequence at the surface of a fibril can modulate seeding, protein-protein interactions, and thereby toxicity in neurodegenerative disease.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34257293     DOI: 10.1038/s41467-021-24411-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  45 in total

1.  Structural features and domain organization of huntingtin fibrils.

Authors:  Charles W Bugg; J Mario Isas; Torsten Fischer; Paul H Patterson; Ralf Langen
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

2.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

3.  Formation and Structure of Wild Type Huntingtin Exon-1 Fibrils.

Authors:  J Mario Isas; Andreas Langen; Myles C Isas; Nitin K Pandey; Ansgar B Siemer
Journal:  Biochemistry       Date:  2017-07-07       Impact factor: 3.162

4.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils.

Authors:  J Mario Isas; Ralf Langen; Ansgar B Siemer
Journal:  Biochemistry       Date:  2015-06-16       Impact factor: 3.162

6.  The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.

Authors:  V N Sivanandam; Murali Jayaraman; Cody L Hoop; Ravindra Kodali; Ronald Wetzel; Patrick C A van der Wel
Journal:  J Am Chem Soc       Date:  2011-03-07       Impact factor: 15.419

7.  Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.

Authors:  Kirupa Sathasivam; Andreas Neueder; Theresa A Gipson; Christian Landles; Agnesska C Benjamin; Marie K Bondulich; Donna L Smith; Richard L M Faull; Raymund A C Roos; David Howland; Peter J Detloff; David E Housman; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

8.  Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.

Authors:  Yoko Nekooki-Machida; Masaru Kurosawa; Nobuyuki Nukina; Kazuki Ito; Toshiro Oda; Motomasa Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

9.  Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation.

Authors:  Songming Chen; Frank A Ferrone; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

10.  Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.

Authors:  Hsiang-Kai Lin; Jennifer C Boatz; Inge E Krabbendam; Ravindra Kodali; Zhipeng Hou; Ronald Wetzel; Amalia M Dolga; Michelle A Poirier; Patrick C A van der Wel
Journal:  Nat Commun       Date:  2017-05-24       Impact factor: 14.919

View more
  4 in total

Review 1.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

2.  Amplification of neurotoxic HTTex1 assemblies in human neurons.

Authors:  Anjalika Chongtham; J Mario Isas; Nitin K Pandey; Anoop Rawat; Jung Hyun Yoo; Tara Mastro; Mary B Kennedy; Ralf Langen; Ali Khoshnan
Journal:  Neurobiol Dis       Date:  2021-09-24       Impact factor: 5.996

Review 3.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 4.  Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease.

Authors:  Kirby M Donnelly; Cevannah M Coleman; Madison L Fuller; Victoria L Reed; Dayna Smerina; David S Tomlinson; Margaret M Panning Pearce
Journal:  Front Neurosci       Date:  2022-08-24       Impact factor: 5.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.